SUMICHEM Sumitomo Chemical India Q4 FY26 results (Jan–Mar 2026) and concall
Sumitomo Chemical India Ltd. reported its highest-ever profitability in FY26, with PAT growing 7% to INR543 crores and record gross and EBITDA margins despite a challenging agrochemical market. The company achieved 3% top-line growth, driven by domestic sales and new product launches, while maintaining a debt-free balance sheet with strong cash reserves. Management highlighted strategic investments in manufacturing, R&D, and digital outreach, alongside a cautious but optimistic outlook for FY27 amidst monsoon uncertainties and raw material cost pressures.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 0.7%, net profit up 11.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 642 | 679 | 1,057 | 930 | 568 −12% | 684 +1% |
| EBITDA | 106 | 120 | 219 | 218 | 99 −7% | 134 +12% |
| Net profit | 87 | 100 | 178 | 178 | 76 −13% | 111 +11% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
